Blood Test May Allow More Precise Antibiotic Use
The infectious disease and genomics experts developed ‘gene signatures’, which are patterns that reflect which of a patient’s genes are turned on or off, to indicate whether someone is fighting infection from a virus or bacteria. Results can be derived from a small sample of the patient’s blood. The study, in which participants with respiratory problems were enrolled during visits to emergency departments at five hospitals, including Duke, the Durham VA Medical Center and UNC Hospital in Chapel Hill, showed these to be 87 percent accurate in classifying more than 300 patients with flu viruses, rhinovirus, several strep bacteria and other common infections, as well as showing when no infection was present.
Senior author Geoffrey S. Ginsburg, MD, PhD, director of Duke’s Center for Applied Genomics & Precision Medicine, said: “In the next five to 10 years, we will likely see new antiviral medications for common bugs like respiratory syncytial virus (RSV) and even rhinovirus, (the predominant cause of the common cold), and guiding treatment choices will be even more important.”
The team previously identified gene signatures associated with viral infections, but this is the first study to distinguish non-infectious illnesses and viral from bacterial infections at the patient’s molecular level. With current technology, measuring a person’s gene expression profile from blood could take as long as 10 hours. Study authors are currently working with developers to create a one-hour test that could be used in clinics.
Source: Duke Health
Image credit: Shawn Rocco/Duke Health
Image caption: Ephraim Tsalik, MD, PhD, at Duke Health assesses a patient for respiratory symptoms.
Published on : Wed, 20 Jan 2016
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
Always in sight, always in mind Features Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands....
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...